Industry News
Blood-brain barrier breached by anti-breast cancer drugs using new technique
Oct 11, 2013
Some breast cancer drugs can penetrate the blood-brain barrier (BBB), but they have not been very effective against brain metastases, whereas other, more effective anti-breast cancer drugs cannot penetrate the BBB at all... Read More
No trace of viral cause for breast cancer and glioblastoma
Oct 11, 2013
A major study conducted at the Sahlgrenska Academy has now disproved theories of a viral cause for breast cancer and the brain tumour, glioblastoma. The study, which was based on over seven billion DNA sequences and which is published in Nature Communications, found no genetic traces of viruses in these forms of cancer... Read More
Studies suggest infusion of blood vessel cells may contribute to organ regeneration in the future
Oct 11, 2013
Damaged or diseased organs may someday be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants, according to scientists at Weill Cornell Medical College... Read More
New method for improving cord blood transplant success
Oct 11, 2013
Starting with a discovery in zebrafish in 2007, Harvard Stem Cell Institute (HSCI) researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that has the potential to improve the success of blood stem cell transplantation... Read More
Sunscreen shields important anti-cancer gene
Oct 10, 2013
Researchers who conducted the world's first study to assess the molecular impact of sunscreen found it offers 100% protection against all three types of skin cancer - basal cell carcinoma, squamous cell carcinoma and malignant melanoma. They also found sunscreen prevents damage to a key anti-cancer gene known as p53... Read More
Adaptive Biotechnologies study reveals homogeneous immune repertoire in solid tumors
Oct 10, 2013
Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, has announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor... Read More
Epigem secures 700,000 Euros of European funding to help anaemia sufferers
Oct 10, 2013
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project... Read More
Sunscreen shields important anti-cancer gene
Oct 10, 2013
Researchers who conducted the world's first study to assess the molecular impact of sunscreen found it offers 100% protection against all three types of skin cancer - basal cell carcinoma, squamous cell carcinoma and malignant melanoma. They also found sunscreen prevents damage to a key anti-cancer gene known as p53... Read More
Combination of anemia and high altitude negatively impacts children with pneumonia
Oct 10, 2013
Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 me... Read More
Epigem secures 700,000 Euros of European funding to help anaemia sufferers
Oct 10, 2013
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project... Read More
Previous Page Next Page